Schedule 13D ownership disclosure

KALOBIOS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 48344T209

Event date: 2016-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,719,006
Percent of class
24.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-16-006035
Form type
SC 13D
Filer
HUMANIGEN, INC
CIK
CIK 1293310
Filed
Jul 13, 2016
Reporting period
Jun 30, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub